BFC Planning’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
BFC Planning's IONS Position: Q3 2026 in Review
BFC Planning reduced its Ionis Pharmaceuticals (IONS) stake by 1.5% in Q3 2026, selling an estimated $57 and leaving 65 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2896.
BFC Planning first reported a position in IONS in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.23K in Q2 2026. 351 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- BFC Planning held 65 shares of Ionis Pharmaceuticals worth $2.9K as of Q3 2026.
- BFC Planning sold 1 Ionis Pharmaceuticals share in Q3 2026, an estimated $57.
- Ionis Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2896 holding.
- BFC Planning first reported a position in Ionis Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Ionis Pharmaceuticals position peaked at $5.23K in Q2 2026.
- 351 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.